Individualized Beta-Blocker Treatment for High Blood Pressure Dictated by Medical Comorbidities: Indications Beyond the 2018 European Society of Cardiology/European Society of Hypertension Guidelines

Post time 2022-7-29 18:52:32

journal：Hypertension

Authors：Giuseppe Mancia; Sverre E. Kjeldsen; Reinhold Kreutz; Atul Pathak; Guido Grassi; Murray Esler

Published date：2022-6-

DOI：10.1161/hypertensionaha.122.19020

Article link：http://dx.doi.org/10.1161/hypertensionaha.122.19020

Article Source：Ovid Technologies (Wolters Kluwer Health)。

Remark：

Post time 2022-7-29 18:52:33

: This post has been completed
Completed attachments will be deleted within 24 hours.

[AHA] Individualized Beta-Blocker Treatment for High Blood Pressure Dictated by Medical Comorbidities: Indications Beyond the 2018 European Society of Cardiology/European Society of Hypertension Guidelines

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[AHA] Individualized Beta-Blocker Treatment for High Blood Pressure Dictated by Medical Comorbidities: Indications Beyond the 2018 European Society of Cardiology/European Society of Hypertension Guidelines Copy

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[AHA] Individualized Beta-Blocker Treatment for High Blood Pressure Dictated by Medical Comorbidities: Indications Beyond the 2018 European Society of Cardiology/European Society of Hypertension Guidelines